Figure 2.
Summary of the Illumina sequencing data. (A) OTUs of samples collected from patients before and after treatment; (B) the sample rank-abundance curve; (C) species accumulation curve; (D) the PCoA analysis. AE, adverse events; T, treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.